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↑What is “already known” in this topic: 
The rate of diabetes and obesity is increasing exponentially. 
The prevalence of cardiovascular risk factors have in-
creased during the recent years among the seafarers in 
various countries. 
→What this article adds: 
The obesity has an increasing among Iranian seafarers working 
on tankers during 2010-2014.This is a main concern because 
obesity has negative effects on the health condition of the sea-
farers. 
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Abstract 
    Background: Little information is available on the trend in cardiovascular risk factors and hepatic enzymes in Iranian seafarers. The 
present study aimed at assessing the pattern of obesity, hypertension, diabetes, elevated serum glutamic oxaloacetate transaminase 
(SGOT), and serum glutamate pyruvate transaminase (SGPT) in Iranian seafarers during 2010 to 2014.  
  Methods: Data on cardiovascular risk factors and hepatic enzymes were extracted from seafarers’ annual health examination of Na-
tional Iranian Tanker Company (NITC) of 2010, 2012, and 2014. The repeated measure ANOVA was used to compare continuous 
variables across 3 years. Categorical data were analyzed using Chi-square test. Over weight was defined as BMI (Body Mass Index) 
>25 kg/m2; obesity was defined as BMI>=30 kg/m2; hypertension was defined as systolic blood pressure (SBP)> 140 mmHg, and dias-
tolic blood pressure (DBP)> 90 mmHg, or a history of antihypertensive drug use. Diabetes (DM) was defined as fasting blood sugar 
(FBS) > 110 mg/dl, or having a history of oral hypoglycemic agents; and elevated SGOT and SGPT were defined as SGOT > 40 U/L 
and SGPT > 40 U/L, respectively.  
  Results: The BMI mean±SD values of Iranian seafarers were 24.81±3.07 kg/m2, 25.51±2.96 kg/m2, and 25.96 ± 3.02 kg/m2 in 2010, 
2012, and 2014, respectively. A significant difference was observed in BMI over the study period. The mean of systolic and diastolic 
blood pressure did not significantly increase over time. The SGOT and SGPT means were not significantly different from 2010 to 
2014. The prevalence of overweight increased significantly from 46.7% to 60.9% over the study period; however, the prevalence of 
obesity, hypertension, elevated SGOT, and elevated SGPT did not change significantly.  
  Conclusion: The current survey showed that the obesity problem has increased among Iranian seafarers working on tankers, which is 
a concerning problem because obesity has negative effects on seafarers’ health. 
Keywords: Seafarer, Cardiovascular, Prevalence, Liver Enzyme, Pattern 
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Introduction 
Cardiovascular disease (CVD) is the main cause of 
death in the world (1), and its prevalence has increased in 
developing countries (2). Overweight, obesity, arterial 
hypertension, and hypercholesterolemia are some of the 
main risk factors causing the highest share of cardiovascu-
lar disease (3). Statistics show that death due to CVD is 
33.7% in low-and middle-income countries (4). The in-
crease in CVD morbidity and mortality in developing 
countries is associated with increased prevalence of cardi-
ovascular risk factors (5). Several research have studied 
the prevalence of cardiovascular risk factors and their 
trends over time in normal population. Data show that 
about 180 million people have diabetes which will be 
doubled by the year 2030 in the developing world (6). The 
prevalence of obesity among adult population was 396 
million in 2005, and it is estimated to reach 573 million by 
D
ow
nl
oa
de
d 
fro
m
 m
jiri
.iu
ms
.ac
.ir 
at 
15
:26
 IR
DT
 on
 S
atu
rda
y J
uly
 15
th 
20
17
    
    
  [ 
DO
I: 1
0.1
88
69
/m
jiri
.31
.23
 ]  
    
 Cardiovascular diseases and liver enzymes risk-factors among Iranian seafarers 
 
 
 http://mjiri.iums.ac.ir 
Med J Islam Repub Iran. 2017 (20 Mar); 31:23. 
 
2 
2030 (7).  
In 2008, a national study in Iran indicated that 7.7% of 
Iranian adults had diabetes, and 16.8% had impaired fast-
ing glucose (8). Also, the estimated total number of Irani-
an obese males and females in 2005 was 42.8% and 57%, 
respectively (9). Based on the current studies on Iranian 
seafarers, the prevalence of MetS (Metabolic Syndrome) 
was 15%, and a large proportion of them had abdominal 
obesity (10). By 2015, these numbers are projected to be 
54% and 74%, respectively (11). Previous studies revealed 
that the prevalence of hypertension among Iranian adults 
was 25.2% in 2005 (12); this figure reached to 26.6% in 
2007 (13). Moreover, the majority of the patients with 
nonalcoholic fatty liver disease (NAFLD), who are obese, 
suffer abdominal obesity, Type 2 diabetes, and other car-
diovascular risk factors (14). Results of the National 
Health and Nutrition Examination Survey (NHANES) 
revealed that about 70% of the elevated aminotransferase 
activity was significantly associated with higher body 
mass index, waist circumference, triglycerides, fasting 
insulin, and lower high density lipoprotein (HDL) choles-
terol (15). 
Seafaring is a crucial job in Iran, and the literature re-
view shows that the prevalence of cardiovascular risk fac-
tors have increased during the recent years among the 
seafarers (16). Moreover, the prevalence of overweight, 
hypertension, and hypercholesterolemia increased during 
1990s and 2000s among seafarers form various countries 
(16). Data revealed that the prevalence of obesity among 
Turkish seafarers has increased, and the highest level of 
BMI was observed among seafarers aged 50 to 60 years 
(17). Little is known about the trend in cardiovascular risk 
factors and hepatic enzymes in Iranian seafarers. Accord-
ingly, the present study aimed at assessing the pattern of 
obesity, hypertension, diabetes, elevated SGOT, and 
SGPT in Iranian seafarers during 2010 to 2014.  
 
Methods 
Data 
A retrospective cohort study was conducted, examining 
500 Iranian male seafarers of NITC, who referred to 
health units for annual health examination to assess some 
patterns of risk factors of cardiovascular disease and liver 
enzymes. From 500 participants, 169 (33%) seafarers had 
at least 6 months of sea services and complete medical-
demographic data in 2010, 2012, and 2014.   
Data on cardiovascular risk factors and hepatic enzymes 
were derived from seafarers’ annual health examination of 
NITC of 2010, 2012, and 2014. The health examination 
data included age, height, weight, FBS, SGOT and SGPT, 
systolic, and diastolic blood pressure. 
Measurement 
Anthropometric parameters including height, weight, 
and blood pressure were measured according to standard-
ized protocols. Weight was measured in light clothing 
without shoes using an electronic scale (Seca, 707; range 
0.1-150 kg); height was measured without shoes using a 
tape meter, stadiometer. Body mass index (BMI) was cal-
culated as weight (kg)/height2 (m2). Systolic and diastolic 
blood pressure were measured twice after 15 minutes rest 
and averaged in seated position, applying a standard mer-
cury sphygmomanometer. 
FBS (after 12-14 hours fasting), SGOT, and SGPT were 
tested using the relevant kits obtained from the Pars 
Azmoon Company, Iran, by an automatic analytical ma-
chine (BT3000, Italy). 
Overweight was defined as BMI>25 kg/m2; obesity was 
defined as BMI>=30 kg/m2. High systole and high diasto-
le were defined as systolic blood pressure (SBP)>140 
mmHg and diastolic blood pressure (DBP)> 90 mmHg, 
respectively. Hypertension was defined as systolic blood 
pressure (SBP)> 140 mmHg and diastolic blood pressure 
(DBP)> 90 mmHg or a history of antihypertensive drug 
use (18). Diabetes was defined as fasting blood glucose > 
110 mg/dL, or having a history of oral hypoglycemic 
agents (18). Elevated SGOT and SGPT were defined as 
SGOT > 40 U/L and SGPT > 40 U/L, respectively (19). 
Ethical Considerations 
This study was proposed and approved by the Ethics-in-
Research Commission of Iran University of Medical Sci-
ences. Also, permission was achieved from NITC to use 
Iranian seafarer information.  
Statistical Analysis  
The data were analyzed using SPSS16. Continuous var-
iables were reported in mean and standard deviation (SD). 
The repeated measure ANOVA was used to compare con-
tinuous variables across 3 years. Categorical data were 
analyzed using Chi-square test. The significant level was 
set at p <0.05. 
 
Results 
The mean (SD) age of Iranian seafarers was 42.8 (10.4) 
years, and the mean (SD) job history was 16.7 (10.60) 
years. A total of 89 (52.7%) and 80 (47.3%) of the partici-
pants had diploma and academic degree, respectively; 77 
(45.6%) did shift work. 
Table 1 demonstrates the mean of BMI, FBS, SBP, 
DBP, and hepatic enzymes among participants in 3 inter-
vals. The BMI mean of the participants significantly in-
creased from 2010 to 2014 (p<0.001). In 2010, the mean 
Table 1. Mean±SD of the cardiovascular risk factors and hepatic enzymes on the participants from 2010 to 2014 
Year, Mean ±SD 
Risk Factors 2010 2012 2014 P-Trend 
BMI 24.81±3.07 25.51±2.96 25.96±3.02 <0.001 
Systolic blood pressure 119.46±13.22 119.14±15.10 122.38±14.41 NS 
Diastolic blood pressure 75.94±8.74 74.95±9.99 78.89±9.49 NS 
Fasting blood glucose 96.24±13.82 95.68±13.40 95.53±18.13 NS 
SGOT 23.76±9.27 21.52±7.93 25.57±9.21 NS 
SGPT 32.29±18.55 28.47±13.92 32.20±16.02 NS 
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(SD) values of SBP and DBP were 119.46 (13.22) mmHg 
and 75.94 (8.74) mmHg, respectively. In 2014, these mean 
values were 122.38 (14.41) mmHg and 78.89 (9.49) 
mmHg, respectively; however, this increase was not statis-
tically significant (p= 0.062). Although the FBS mean 
decreased over the study period, it was not statistically 
significant (p= 0.22). The mean values of SGOT and 
SGPT did not change significantly among participants 
from 2010 to 2014. 
The prevalence of cardiovascular risk factors and hepat-
ic enzyme among Iranian seafarers are presented in Table 
2. The prevalence of overweight increased significantly 
from 46.7% to 60.9% over the study period. Although the 
prevalence of obesity enhanced from 4.1% to 8.9%, it was 
not statistically significant. The rate of high SBP, high 
DBP, HTN, and diabetes increased from 2010 to 2014; 
however, the changes were not significant. The prevalence 
of elevated SGOT and SGPT were 6.5% and 25.4% in 
2010, respectively; this prevalence was 5.9% and 21.3% 
in 2014, respectively, indicating no significant change 
between 2010 and 2014 prevalence values.   
Figures 1-3 demonstrates the frequency of different 
combinations of cardiovascular risk factors from 2010 to 
2014. The prevalence of having “HTN and obesity” did 
not change significantly over time, but the frequency of 
having “HTN and overweight” significantly increased 
from 12.4% to 17.8%. The frequency of combination of 
DM-overweight significantly increased from 2010 to 
2014. Also, the prevalence of having diabetes-overweight-
HTN among Iranian seafarers increased significantly from 
5.3% to 5.9% between 2010 until 2014 (p<0.05).  
 
Discussion 
The current study provides primary data on the increas-
ing trend of overweight in Iranian seafarers’ population 
over the study period. The prevalence of hypertension, 
diabetes, elevated SGOT, and SGPT increased non-
significantly from 2010 to 2014. Studies have found that 
the risk factors of non-communicable diseases’ trend have 
been increasing in both developing and developed coun-
tries (20-22). The prevalence of obesity among American 
adults increased from 13% to 32% between 1960s and 
2004 (23, 24). Similar increasing trend of diabetes is re-
ported in adults’ population in the USA (25). The preva-
lence of obesity in Europe has doubled over the past 10 to 
15 years (26). In developing countries, the increasing 
prevalence of diabetes is estimated to increase from 3.3% 
to 4.9% from 1995 to 2025 (27). A similar increase in 
obesity prevalence has been observed in developing coun-
tries (20); in Kuwait and Oman, the obesity prevalence 
rate has risen in recent years. The national prevalence of 
obesity in Kuwait increased from 15% to 28% from 1980 
to 1994 (28), and in Oman, it increased from 10.5% to 
16.7% from 1991 to 2000 (29). Recent studies have re-
vealed that cardiovascular diseases risk factors have also 
increased in Iranian adults’ population (3, 13, 30, 31). 
Data from the National Survey of Risk Factors of Non-
Communicable Diseases (SuRFNCD) showed that the 
Table 2. Prevalence of cardiovascular risk factors and hepatic enzymes on the participants from 2010 to 2014 
Year, Prevalence, % 
Risk factors 2010 2012 2014 Relative Change From 2010 to 2014, % P value 
Obesity 7 (4.1) 10 (5.9) 15 (8.9) 114 NS 
Overweight 79 (46.7) 99 (58.6) 103 (60.9) 30.37 <0.01 
High systole 16 (9.5) 20 (11.8) 25 (14.8) 56.25 NS 
High diastole 20 (11.8) 35 (20.7) 24 (14.2) 20 NS 
Hypertension 26 (15.4) 41 (24.3) 40 (23.7) 53.84 NS 
Diabetes 37 (21.9) 33 (19.5) 49 (29.0) 32.43 NS 
Elevated SGOT 11 (6.5) 4 (2.4) 10 (5.9) -9.09 NS 
Elevated SGPT 43 (25.4) 25 (14.8) 36 (21.3) -16.27 NS 
Overweight& Hypertension 21 (12.4) 26 (15.4) 30 (17.8) 42.85 NS 
Overweight& Diabetes 23 (13.6) 16 (9.5) 28 (16.6) 21.73 NS 
Hypertension& Diabetes 10 (5.9) 8 (4.7) 10 (5.9) 0 NS 
Hypertension& Diabetes& Overweight 27 (16.9) 35 (21.3) 38 (23.9) 40.74 NS 
Elevated SGOT& Elevated SGPT 10 (5.9) 4 (2.4) 7 (4.1) -30.0 NS 
 
 
*P<0.05 
Fig. 1. Frequency of Combination of HTN; a: Obesity, b: Overweight 
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prevalence of obesity increased from 13.6% in 1999 to 
19.6% in 2005 and to 22.3% in 2007 among Iranian 
adults. During these years, the national prevalence of 
overweight was 32.2%, 35.8%, and 36.3%, respectively; 
ie, 4.1% increase in 8 years (3). According to SuRFNCD, 
the rate of diagnosed diabetes was 2.5%, 4.0%, and 4.6% 
in 1999, 2005, and 2007, respectively; ie, during 8 years, 
the prevalence of diabetes rose more than 1.8 fold among 
Iranian adults (31). In 2005, the national prevalence of 
hypertension was 25.2%; this number was 26.6% (1.4% 
increase in 2 years) in 2007 (13). Other studies presented 
alarming increases in the prevalence of overweight, obesi-
ty, and abdominal obesity in different regions of Iran (30, 
32, 33). Possible reasons which can be accounted for in-
crease in the prevalence of non-communicable diseases 
are improper dietary habits, inactivity, speedy urbaniza-
tion, and imparity in health care (34).  
The prevalence of cardiovascular risk factors are high 
among seafarers, which might be due to their different 
lifestyle (16). In the current study, the overweight trend 
increased significantly among seafarers by 14.2% from 
2010 to 2014. The mean of BMI significantly increased 
among Iranian seafarers over time. The present findings 
are consistent with other studies (16, 17, 35). A review on 
the prevalence of cardiovascular risk factors among sea-
farers during 1990s and 2000s showed that the prevalence 
of overweight was 47.1% in 1990s and 64.1% in 2000s; 
and the prevalence of overweight increased significantly 
over time (16). Findings of Nas revealed that the mean of 
BMI among Turkish seafarers significantly raised from 
2009 to 2012, and when the Turkish seafarers got older, 
their BMI values increased gradually (17). A survey was 
performed among Danish seafarers to find the trend of 
BMI from 2001/2002 to 2010, showing that the over-
weight prevalence was 64% in 2001/2002 and increased to 
70.5% in 2010; and the relative risk of being overweight 
in 2010 was 1.08 compared to 2001/2002 (35). Published 
data show that the prevalence of high blood pressure sig-
nificantly increased from 14.8% in 1990s to 42.1% in 
2000s among seafarers (16), which is inconsistent with the 
present study. In our study, the mean of SBP and DBP did 
not increase significantly, and the trend of high systole, 
high diastole, and hypertension rose nonsignificantly 
among Iranian seafarers from 2010 to 2014. The findings 
revealed that the mean of fasting blood glucose did not 
change significantly over time, and the trend of diabetes 
did not increase significantly. The results are consistent 
with Pougnet et  al.’s study (16), in which the prevalence 
of glycemic abnormalities or diabetes increased nonsignif-
icantly from 3.9% to 4.0% during 1990s and 2000s. Doc-
umentaries show that factors such as inactivity, lack of 
sleeping, stress of work, unhealthy diet, and long job dura-
tion contribute to increase in cardiovascular risk factors 
among seafarers (36).  
In our study, the mean of hepatic enzymes increased 
non-significantly from 2010 to 2014 among Iranian sea-
farers, hich might have been due to the short duration of 
the study or small sample size. Elevated level of SGPT is 
the main liver abnormality in NAFLD and nonalcoholic 
steatohepatitis (NASH). Statistics showed that the 
NAFLD prevalence was 25% among American adults 
(37). Previous studies have revealed significant associa-
tions between components of metabolic syndrome and 
NAFLD and NASH (38). The prevalence of elevated 
SGPT among Iranian population is 4.3%, suggesting that 
the rate of NAFLD/NASH and related complications are 
expected to rise among Iranian population in the future 
(39). Recent evidences indicate that NAFLD is the main 
common reason of liver disease in Iran (40). 
The main strength of the study was that it was the first 
study to report the pattern of cardiovascular risk factors 
and liver enzymes among Iranian seafarers working on 
tankers. The study had a number of limitations: Nutrition-
al habits and physical activity were not considered simul-
*P<0.05 
Fig. 2. Frequency of combination of diabetes. a: Overweight, b: HTN 
 
*P<0.001 
Fig. 3. Frequency of combination of diabetes and HTN and over-
weight 
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taneously in the study, moreover, the study was conducted 
in a short-term; and in this regard small sample size might 
have been the main reason for non-significant results of 
the current survey. Thus, the results may not be appropri-
ately generalized.   
 
Conclusions 
The current survey showed that the obesity problem has 
increased among Iranian seafarers working on tankers in 
the recent years, which is a main concern because obesity 
has negative effects on the health condition of the seafar-
ers. Longitudinal studies on seafarers are needed to inves-
tigate the trend of cardiovascular risk factors and other 
risk factors of this occupation. 
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